
Number of publications published per year by Factor, Valentina M.. (Source : PubMed)

Distribution of publications types for Factor, Valentina M.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Progenitor-derived hepatocellular carcinoma model in the rat.
Hepatology
2009

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
Oncogene
2009;28;40

Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
Cancer Res.
2009;69;7

E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
Gastroenterology
2008;135;4


Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.
Hepatology
2008;47;6
Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro.
Am. J. Pathol.
2008;172;5

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
Cancer Res.
2007;67;20

Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
J. Clin. Invest.
2007;117;9

Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver.
Hepatology
2006;44;6

Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
Hepatology
2006;44;4
[ See timeline ] [ See all publications ]
means that Factor, Valentina M. has 25 papers cited a least 25 times - methodology
Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.